Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions consistently endorse the finding that OAC monotherapy offers similar ischemic outcomes with reduced bleeding risks, using language like 'less may be more' and 'surprising news,' which conveys both support and a recognition of clinical significance. The tone varies from supportive remarks to practical insights, illustrating deep engagement and acknowledgment of the study's importance for patient care and treatment strategies.
Most posts express support or acknowledgment of the findings, indicating broad agreement with the article’s conclusions.
Discussions demonstrate high interest, with multiple posts emphasizing the implications for clinical practice and patient management.
Posts reference specific results and recommendations, showing in-depth engagement with the research methodology and outcomes.
The posts highlight the potential influence on treatment guidelines and clinical decision-making, reflecting substantial impact.
In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statistically significant increased risk of ischemic events but resulted in a significantly reduced risk of bleeding. https://t.co/vOen1sLSZX #JACC #cvCoag @bbikdeli https://t.co/87qpzyJBfE
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not associated with a statistically significant increased risk of ischemic events but resulted in a significantly reduced risk of bleeding. https://t.co/diOEXf8BVf https://t.co/2CnPASZI2F
Da la sensación de que con la información que tenemos la monoterapia con Anticoagulación es suficiente para la mayoría de pacientes con enfermedad coronaria crónica y FA.
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease, Meta-Analysis of Randomized Trials 2025 #Cardiology #Anticoagulation
Silent cerebral embolism and antithrombotic strategies in patients with AF and CAD are the focus of this podcast featuring John Mandrola MD. Explore the implications of recent studies on stroke prevention and management…
Prof. Bikdeli and Prof. Didier discuss the HIPRO study on extended treatment of provoked venous thromboembolism, presented at the 2025 European Society of Cardiology meeting. The study compares rivaroxaban monotherapy…
"In patients with AF and stable CAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statistically significant increased risk of ischemic events but resulted in a significantly reduced risk of bleeding." @JACCJournals https://t.co/fxZBx8lqN5
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease @JACCJournals https://t.co/yEmSO7pooQ https://t.co/h97zvIgTEt
RT @RichardAFerraro: We sort of already knew this, but good work in @JACCJournals to further promote best practices and ⬇️ polypharmacy for…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @ZHeart11768530:
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @ZHeart11768530:
AFIREを含めたRCTの個別患者データのメタ解析が出ています。Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials | JACC https://t.co/QuJRsBPYFy
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not a…
RT @ZHeart11768530:
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease OAC monotherapy, was not associated with a statistically significant increased risk of ischemic events but resulted in a significantly reduced risk of bleeding. https://t.co/diOEXf8BVf https://t.co/2CnPASZI2F
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials | JACC https://t.co/CEpzVM9Vnd
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
RT @JACCJournals: In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statist…
In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statistically significant increased risk of ischemic events but resulted in a significantly reduced risk of bleeding. https://t.co/vOen1sLSZX #JACC #cvCoag @bbikdeli https://t.co/87qpzyJBfE
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Rand… https://t.co/tDnMevFmRz
Meta-analysis of 4 RCTs finds that for pts with AFib and stable CAD, OAD alone reduced risk of bleeding w/o increasing risk of thrombotic events @JACCJournals https://t.co/fxZBx8lqN5
RT @ZHeart11768530:
RT @preopconsult: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized…
RT @preopconsult: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized…
RT @preopconsult: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized…
RT @preopconsult: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized…
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials | JACC https://t.co/dCDFC4WghE https://t.co/HbUnglEdr8
RT @jsobrinom: Anticoagulación (ACO) y tratamiento antiplaquetario (APT) para la fibrilación auricular y la enfermedad coronaria estable: m…
Anticoagulación (ACO) y tratamiento antiplaquetario (APT) para la fibrilación auricular y la enfermedad coronaria estable: metanálisis de ensayos aleatorizados | JACC https://t.co/B7andOPbhs @Sociedad_SEMI https://t.co/oOcuIfNT7c
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Rand… https://t.co/BYxAONDF1K
RT @jpcostabel: Da la sensación de que con la información que tenemos la monoterapia con Anticoagulación es suficiente para la mayoría de p…
Out in @JACCJournals Less may be more for AF & stable CAD. Oral anticoagulation monotherapy had similar ischemic outcomes but lower major bleeding risk vs. oral anticoagulation + single antiplatelet therapy.
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease - ClinicalKey https://t.co/Mhc6z6EXA6
RT @RichardAFerraro: We sort of already knew this, but good work in @JACCJournals to further promote best practices and ⬇️ polypharmacy for…
【メタアナリシス】心房細動を伴う安定型冠動脈疾患での抗凝固と抗血小板療法（経口抗凝固薬単剤と抗血小板薬併用間で心筋梗塞、虚血性脳卒中、全身性塞栓症や死亡の複合転帰について差はなかった一方、単剤療法は大出血のリスク減少と関連した。） #ペ読 https://t.co/YHE7AHAi58
RT @N_Earth7: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease, Meta-Analysis of Randomized Tri…
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials. https://t.co/1cQ3V1tbJK
RT @N_Earth7: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease, Meta-Analysis of Randomized Tri…
RT @N_Earth7: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease, Meta-Analysis of Randomized Tri…
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease, Meta-Analysis of Randomized Trials 2025 #Cardiology #Anticoagulation
RT @ZHeart11768530:
RT @jpcostabel: Da la sensación de que con la información que tenemos la monoterapia con Anticoagulación es suficiente para la mayoría de p…
RT @jpcostabel: Da la sensación de que con la información que tenemos la monoterapia con Anticoagulación es suficiente para la mayoría de p…
RT @jpcostabel: Da la sensación de que con la información que tenemos la monoterapia con Anticoagulación es suficiente para la mayoría de p…
RT @RichardAFerraro: We sort of already knew this, but good work in @JACCJournals to further promote best practices and ⬇️ polypharmacy for…
RT @ZHeart11768530:
RT @ZHeart11768530:
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Rand… https://t.co/k7UTUEU8Qh
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @RichardAFerraro: We sort of already knew this, but good work in @JACCJournals to further promote best practices and ⬇️ polypharmacy for…
Da la sensación de que con la información que tenemos la monoterapia con Anticoagulación es suficiente para la mayoría de pacientes con enfermedad coronaria crónica y FA.
RT @ZHeart11768530:
RT @RichardAFerraro: We sort of already knew this, but good work in @JACCJournals to further promote best practices and ⬇️ polypharmacy for…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis Randomized T…
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials | Journal of the American College of Cardiology https://t.co/ifaSnDw0hC
RT @drbennisahmed: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis Randomized T…
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis Randomized Trials OAC monotherapy, compared with OAC plus SAPT, not associated with a statistically significant increased risk of ischemic events https://t.co/diOEXf8BVf https://t.co/XiS37r1hfN
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials https://t.co/FCTmq3qXrY
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials | Journal of the American College of Cardiology https://t.co/YRmkb3Vubh
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials - ScienceDirect The least surprising news… drop the anti platelet for stable coronary artery disease and Afib! https://t.co/VUPTWS9PmX
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials | Journal of the American College of Cardiology https://t.co/CbYenB9cBS
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials @LHCHFT @LJMU_Health @LivuniILCaMS @LJMU_Health #Afib https://t.co/knYKGGj9z5 https://t.co/FqpNUPJHd9
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials | Journal of the American College of Cardiology @livuni-ilcams.bsky.social @livhp.bsky.social #Afib www.jacc.org/doi/10.1016/...
https://t.co/JhhS9qxShc cc @djc795
doi: 10.1016/j.jacc.2017.10.039. 8. Sorajja P, Whisenant B, Hamid N, et al ... doi: 10.1016/j.jcin.2024.12.030. 25. Fam NP, Ong G, Estevez-Loureiro R, et ...
org/doi/10.1016/j.jacc.2024.12.030）。本研究は、特定の高リスク患者集団において、経口抗凝固薬にアスピリンを追加する戦略が有害であることを明確に ...
https://doi.org/10.1016/j.jacc.2024.12.030. Title: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta ...
... 10.1016/j.jacc.2024.12.030. 2 Rashedi et al JACC VOL. -, NO. -, 2025. Antithrombotic Therapy in AF and Stable Coronary Disease -, 2025:-–-. A trial ...
DOI: https://doi.org/10.1016/j.jacc.2024.12.030 Title: Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary ...
... (J-CTO 1 punto, calcificación). Procedimiento: Paso 1.- acceso ... doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · seth_trombosis's ...
... , et al. Journal of the American College of Cardiology. 2025;85(11):1189-1203. doi:10.1016/j.jacc.2024.12.030.".
Este ano foi histórico para a Doença de Chagas: tivemos o ANSWER-HF publicado no JACC ... doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · dr.
... ):1189-1203. doi:10.1016/j.jacc.2024.12.030. more. 3 days ago · medicinainterna.unimetro's profile picture · medicinainterna.unimetro. •. Follow.
https://doi.org/10.1016/j.recesp.2025.06.009 #cardio ... doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · medecs_cardiologia's ...
... Cardiology. 2025;85(11):1189-1203. doi:10.1016/j.jacc.2024.12.030. more. 3 days ago · diego_ketamino's profile picture · diego_ketamino. •.
doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · espinosawenceslao's profile picture. espinosawenceslao. •. Follow.
2025;85(11):1189-1203. doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · cardioanestesia.pro's profile picture. cardioanestesia.pro. •. Follow.
REFERENCIA: https://doi.org/10.1016/j.jcin.2025.10.005 ... 2025;85(11):1189-1203. doi:10.1016/j.jacc.2024.12.030. more. 2 days ...
Journal of the American College of Cardiology. 2025;85(11):1189-1203. doi:10.1016/j.jacc.2024.12.030. more. 3 days ago · tuhematologa. •. Follow.
... J Am Heart Assoc. 2020;9(13):e017559. - Circulation. 2023 ... doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · eldoctorhenao's ...
... 10.1016/j.jacc.2025.05.023 #Pericarditis #Cardiología #Médicos #Residentes #ActualizaciónMédica #EducaciónContinua".
... American College of Cardiology. 2025;85(11):1189-1203. doi:10.1016/j.jacc.2024.12.030. more. 2 days ago. cardiologiamedicinainternaba. •. Follow.
#JACC nos entrega la actualización del infarto agudo del miocardio ... doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · solaci_oficial's ...
doi.org/10.1016/j.jchf… more. December 3 · somoscardiosaludca's ... doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · Sign up • Instagram.
REFERENCIA: https://doi.org/10.1016/j.jcin.2025.10.005 . . . . ... doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · solaci_oficial's ...
doi:10.1016/j.jacc.2024.12.030. more. 1 day ago · Sign up • Instagram · Meta · About · Blog · Jobs · Help · API · Privacy · Consumer Health ...
doi:10.1016/j.jacc.2024.12.030. more. 2 days ago. Accounts you might like. See all · punto_enarm's profile picture. punto_enarm. Punto ENARM.
https://doi.org/10.1016/j.recesp.2025.06.009 #cardio ... doi:10.1016/j.jacc.2024.12.030. more. 2 days ago · solaci_oficial. •. Follow.
doi:10.1016/j.jacc.2024.12.030. more. 3 days ago · eldoctorhenao's profile picture · eldoctorhenao. •. Follow.
Este documento de posición del JACC Heart Failure 2025 ... doi:10.1016/j.jacc.2024.12.030. more. 3 days ago. medinternafacil. •. Follow.
... Pan, et al. JACC: CARDIOVASCULAR INTERVENTIONS, Article in Presshttps://doi.org/10.1016/j.jcin.2024.12.030. #cardiopatiaestructural ...
... 2024.12.030 #Cardiology #FOAMed #MedEd #medstudent #paramedic ... https://www.jacc.org/doi/10.1016/j.jacc. 2024.12.030 #Cardiology ...
... JACC Cardiovasc Interv 2025; DOI: 10.1016/j.jcin.2024.12.030. Secondary Source. JACC: Cardiovascular Interventions. Source Reference: Fam NP ...
https://www.jacc.org/doi/10.1016/j.jacc. 2024.12.030?utm_medium=social&utm_source=twitte r_post&utm_campaign=twitter_post #FOAMed #MedEd ...
... jacc.org/doi/abs/10.1016/j.jacc. 2024.12.030 #POCUS #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter ...
https://www.jacc.org/doi/10.1016/j.jacc. 2024.12.030 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter ...
TH
JJ
AM
JM
DA
DS
EM
AA
SZ
NM
SC
DC
GO
EJ
JS
DD
C
DK
RP
KP
MT
P
RB
JM
A
LM
JC
KD
MM
DJ
A
TF
KF
HF
AK
TP
D
BF
OH
LM
KP
IO
GF
HM
NH
SM
BR
NR
LA
JB
V
SA
OW
DV
LL
J
SR
SA
DC
PS
A
MH
ED
NS
SM
S
JM
た
G
SA
BM
VS
P
に
RA
DS
GL
AG
FZ
IM
V
A
JR
AG
G
JF
D
GP
DV
EJ
ㅡ
MG
EM
AA
JN
DC
DS
TH
JA
FF
LS
JM